Synnat Pharma Private Limited, a active private limited company, was established on 31 May 2011 in Serilingampally, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2011PTC074746. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹0.66 M.
It upholds a compliant status. Employing 189 professional, Its leadership includes Siddharth Karnani (Director), Ramesh Kumar Karnani (Director), Karnani Ritesh (Director). Past directors included Sohan Lall Karnani, Siddharth Karnani, Karnani Ritesh. It holds ₹25.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3Rd Floor, Tower-2 (Eastern Side), Vamsirams Jyothi Granules, Kondapur, Serilingampally, Telangana, 500084.
U24232TG2011PTC074746
074746
31 May 2011
₹3.00 Cr
₹0.66 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Synnat Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddharth Karnani | Director | 03 Dec 2022 | Current |
| Ramesh Kumar Karnani | Director | 31 May 2011 | Current |
| Karnani Ritesh | Director | 03 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Feb 2023 | Past |
| Pramod Abcsdd | Additional Director | 03 Dec 2022 | Past |
| Pramod Abcsdd | Additional Director | 03 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synnat Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Synnat Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹250,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2025 | Others | ₹10.00 Cr | Open |
| 30 Aug 2025 | Others | ₹15.00 Cr | Open |
Explore comprehensive loan charge details -
Synnat Pharma has a workforce of 189 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Synnat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synnat Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101166436 was registered on 30 Aug 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101166435 was registered on 30 Aug 2025. was documented.
Synnat Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Synnat Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Siddharth Karnani was appointed as a Director was appointed as a Director on 03 Dec 2022 & has been associated with this company since 2 years 11 months . was recorded as a recent event.
Progress on Karnani Ritesh was appointed as a Director was appointed as a Director on 03 Dec 2022 & has been associated with this company since 2 years 11 months . was documented.
The CIN of Synnat Pharma Private Limited is U24232TG2011PTC074746.
Synnat Pharma Private Limited is headquartered at 3Rd Floor, Tower-2 (Eastern Side), Vamsirams Jyothi Granules, Kondapur, Serilingampally, Telangana, 500084.
Synnat Pharma Private Limited was incorporated on 31 May 2011.
The current directors of Synnat Pharma Private Limited are
The primary industry of Synnat Pharma Private Limited is Manufacturing.
Synnat Pharma Private Limited is unlisted.
The authorized capital of Synnat Pharma Private Limited is ₹3.00 Cr, and the paid-up capital is ₹0.66 M.
The compliance status of Synnat Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX